Deal snapshot: ZALGEN LABS LAUNCHES VIRAL DIAGNOSTICS BUSINESS FOLLOWING TRANSFER FROM CORGENIX MEDICAL.
US-based biotechnology and diagnostics company Zalgen Labs has received via transfer the viral hemorrhagic fever diagnostics business from diagnostic test kit developer Corgenix Medical Corp. and opened an advanced product development centre in the Fitzsimons Bioscience Park Center on the University of Colorado Anschutz Medical Campus in Aurora, Colorado, the company said.
In November 2013, Corgenix Medical and Zalgen Labs entered into a collaboration agreement to the development of multiple diagnostic testing platforms and immunotherapeutics for high impact neglected infectious diseases.
Target: Corgenix Medical/viral hemorrhagic fever diagnostics business
Buyer: Zalgen Labs
Vendor: Corgenix Medical Corp
Deal size in USD:
Buyer advisor: , ,
Comment: Part of deal hatched in 2013
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Aug 23, 2016|
|Previous Article:||UK Competition and Markets Authority Publishes Decision on Hammerson's Acquisition of Birmingham Shopping Centre.|
|Next Article:||Deal snapshot: WESBANCO RECEIVES REGULATORY APPROVALS FOR USD 221M YOUR COMMUNITY ACQUISITION.|